重大公告
Announcement of explanation on the Company’s criminal lawsuit against Next Magazine
Parties to the legal matter: OBI Pharma, Inc. Name of the court or disposing agency: Shihlin District Prosecutors Office, Taiwan Reference/case numbers of relevant documents: …
OBI-833, the cancer therapeutic vaccine, has met the primary safety indicators in Phase I clinical trial for US and Taiwan
Date of occurrence of the event: April 6, 2017 Company name: OBI Pharma, Inc. Relationship to the Company (please enter ”head office” or ”affiliated company”): …
The board of directors have resolved not to distribute dividends
Date of the board of directors resolution : 9 Mar 2017 (1) Appropriations of earnings in cash dividends to shareholders (NT$ per share): 0 (2) …
Announcement by the Company’s Board of Directors to convene the 2016 Annual General Shareholders’ meeting
Date of the board of directors resolution: Thursday 9 March 2017 Date for convening the shareholders’ meeting: Wednesday 28 June 2017 Location for convening the …
OBI Pharma’s Board of Directors approves the announcement of the Company’s 2016 individual and consolidated financial statements
Date of the Event: 9 Mar 2017 Company Name: OBI Pharma, Inc Relationship to the Company (enter “Parent” or “Subsidiary”: Parent Reciprocal shareholding ratios: N/A …